Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 984 entries
View as:

Perianal Fistula (PAF) Validation and Burden of Illness Study

Phase: N/A Priority: Normal
NCT ID: NCT03981939 Org: User:
Start: 07/02/19 End: 12/31/19 Due: 12/31/20

Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT03332784 Org: User:
Start: 11/04/17 End: 09/04/18 Due: 09/04/19

A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788

Phase: N/A Priority: Normal
NCT ID: NCT04576208 Org: User:
Start: 11/30/20 End: 07/31/22 Due: 07/31/23

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01568385 Org: User:
Start: 04/30/12 End: 09/30/13 Due: 09/30/14

An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004

Phase: N/A Priority: Normal
NCT ID: NCT03596164 Org: User:
Start: 07/09/18 End: 01/13/22 Due: 01/13/23

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Phase: N/A Priority: Normal
NCT ID: NCT02756832 Org: User:
Start: 09/20/16 End: 04/28/18 Due: 04/28/19

Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02396147 Org: User:
Start: 03/31/15 End: 06/30/15 Due: 06/30/16

A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02613221 Org: User:
Start: 12/07/15 End: 03/30/18 Due: 03/30/19

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02413255 Org: User:
Start: 03/18/15 End: 05/04/17 Due: 05/04/18

Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00756002 Org: User:
Start: 08/31/07 End: 03/31/08 Due: 03/31/09

Long-Term Safety of Febuxostat in Subjects With Gout.

Phase: N/A Priority: Normal
NCT ID: NCT00174941 Org: User:
Start: 03/31/01 End: 12/31/06 Due: 12/31/07

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00759551 Org: User:
Start: 08/31/04 End: 06/30/05 Due: 06/30/06

A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience

Phase: N/A Priority: Normal
NCT ID: NCT05602818 Org: User:
Start: 11/15/22 End: 07/07/23 Due: 07/07/24

Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT01135368 Org: User:
Start: 06/30/02 End: 09/30/08 Due: 09/30/09

Single-Dose Study of MT203

Phase: N/A Priority: Normal
NCT ID: NCT02354599 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06290050 Org: User:
Start: 03/29/24 End: 05/16/24 Due: 05/16/25

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01647542 Org: User:
Start: 10/31/12 End: 03/31/14 Due: 03/31/15

A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03085836 Org: User:
Start: 04/19/17 End: 08/17/17 Due: 08/17/18

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00760344 Org: User:
Start: 03/31/07 End: 03/31/08 Due: 03/31/09

A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT03173092 Org: User:
Start: 11/13/17 End: 11/30/26 Due: 11/30/27

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00775814 Org: User:
Start: 10/31/06 End: 09/30/08 Due: 09/30/09

Double-blind Comparative Study of SYR-472

Phase: N/A Priority: Normal
NCT ID: NCT01632007 Org: User:
Start: 05/01/12 End: 07/01/13 Due: 07/01/14

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

Phase: N/A Priority: Normal
NCT ID: NCT02899884 Org: User:
Start: 11/14/16 End: 07/16/18 Due: 07/16/19

Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)

Phase: N/A Priority: Normal
NCT ID: NCT02037477 Org: User:
Start: 01/31/14 End: 03/31/14 Due: 03/31/15

Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00756041 Org: User:
Start: 09/30/05 End: 09/30/06 Due: 09/30/07